John A. Axelson

Gefitinib in patients with chemo-sensitive and chemo-refractory relapsed small cell cancers: A Hoosier Oncology Group phase II trial

Annette M. Moore, Lawrence H. Einhorn, D. Estes et al. · Lung Cancer · 2006 · 93 citations

Medicine, Oncology, Pharmacology +8

Quantification of platelet-bound IgG by 125I-Staphylococcal protein A in immune thrombocytopenic purpura and other thrombocytopenic disorders

John A. Axelson, JG Maglott, AF LoBuglio · Blood · 1984 · 34 citations · Full text

Life Sciences, Hematology, Immunology +12

Counseling and development in a multicultural society, 2nd ed.

John A. Axelson · 1993 · 18 citations

Education, Counseling, Psychology +12

A Phase II Trial of Intermittent Leukocyte Interferon and High Dose Chlorambucil in the Treatment of Non-Hodgkinʼs Lymphoma Resistant to Conventional Therapy

Ray H. Clark, Nikolay V. Dimitrov, John A. Axelson et al. · American Journal of Clinical Oncology · 1989 · 13 citations

Medicine, Hematology, Oncology +15

Leukocyte interferon as a possible biological response modifier in lymphoproliferative disorders resistant to standard therapy.

Ray H. Clark, Nikolay V. Dimitrov, John A. Axelson et al. · PubMed · 1984 · 13 citations

Medicine, Hematology, Pharmacology +16